On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.
Skeletal

Kniest dysplasia

This condition leads to short stature, characteristic facial features, and issues with joints, hearing, and vision. It is present from birth and is caused by changes in the *COL2A1* gene, which is vital for cartilage formation.

Autosomal dominant Skeletal OMIM:156550
Rare
Prevalence
Population estimate
50%
Inheritance
Autosomal dominant - chance of passing to each child
1
Associated genes
COL2A1

Available at Jeen Health

Clinical tests that include this

Overview

Kniest dysplasia is a rare inherited condition that impacts skeletal development and growth throughout the body [PMID:30138927]. Individuals with Kniest dysplasia typically have short stature, joint problems, and distinct facial features. The condition is named after Dr. Wilhelm Kniest, who first described it in 1952. It is present from birth, meaning affected individuals show signs and symptoms from an early age.

The condition affects connective tissues, particularly cartilage, which is a flexible tissue found in many parts of the body, including joints, the spine, and the ears and nose. Problems with cartilage development can lead to a range of physical challenges that vary in severity among affected individuals.

Symptoms & clinical features

Key symptoms of Kniest dysplasia often include short stature, a shortened trunk, and limbs that may appear disproportionately short [PMID:10729221]. Joint issues are common, including joint stiffness and enlargement, which can limit movement and sometimes lead to early-onset osteoarthritis. Some individuals may also experience kyphoscoliosis, a curvature of the spine.

Distinct facial features are often observed, such as a flattened midface, a broad forehead, and widely spaced eyes. Other potential symptoms can include cleft palate, clubfoot, and eye problems like myopia (short-sightedness) or retinal detachment. Hearing impairment, sometimes progressive, is also a feature for some people with Kniest dysplasia [PMID:10729221].

Video: Genetics 101

Affected organs

Kniest dysplasia primarily affects the skeletal system, leading to abnormalities in bone and cartilage development throughout the body. This includes the long bones of the limbs, the vertebrae of the spine, and the cartilage in joints, leading to joint pain and mobility issues. The eyes can also be affected, with myopia being common, and in some cases, retinal detachment may occur. Hearing can be impaired due to issues with the bones of the middle ear or the structure of the inner ear. The palate can also be affected, sometimes resulting in a cleft palate.

Multiple body systems
Multiple body systems
Systemic involvement
Cellular impact
Cellular impact
Mechanism at cellular level

Risks & severity

The severity of Kniest dysplasia can vary significantly between individuals. Most affected individuals will experience some degree of short stature, joint problems, and characteristic facial features. The condition is present from birth, and symptoms may become more apparent as a child grows.

Complications such as progressive joint degeneration and spinal curvature can lead to increasing challenges with mobility over time. Vision and hearing impairments can also range from mild to severe. Regular monitoring and supportive care are important for managing these potential risks and improving quality of life.

Genetic causes

Kniest dysplasia is caused by changes (pathogenic variants) in the *COL2A1* gene [PMID:30138927]. This gene provides instructions for making a protein called the alpha-1(II) chain, which is a crucial component of type II collagen. Type II collagen is a major building block of cartilage and other connective tissues found throughout the body, including the clear jelly-like substance (vitreous humour) in the eye.

When there are pathogenic variants in *COL2A1*, the body cannot produce normal type II collagen, or it produces a faulty version. This disrupts the proper formation and structure of cartilage, leading to the skeletal abnormalities, joint problems, and other features observed in Kniest dysplasia. The nature of the specific genetic change in *COL2A1* can influence the severity of the condition.

  • COL2A1
    collagen type II alpha 1 chain
    The COL2A1 gene provides the genetic blueprint for assembling the alpha-1(II) chain, a foundational component of type II collagen, which is essential for the structural integrity of cartilage and other connective tissues.

Inheritance pattern

Kniest dysplasia follows an autosomal dominant inheritance pattern. This means that a person only needs one copy of the altered *COL2A1* gene in each cell to develop the condition. In many cases, the genetic change occurs spontaneously in the affected individual and is not inherited from a parent; this is known as a de novo variant.

If a person has Kniest dysplasia, there is a 50% chance that each of their children will also inherit the altered gene and develop the condition. This risk applies to each pregnancy. Family members of someone diagnosed with Kniest dysplasia may be offered genetic counselling to discuss inheritance patterns and testing options.

♀ Affected parent 1 altered copy ♂ Unaffected parent 2 typical copies Affected Unaffected Unaffected Affected Affected Carrier Unaffected Circles = females · Squares = males

Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.

Diagnosis & testing

A diagnosis of Kniest dysplasia is typically suspected based on characteristic clinical features observed during a physical examination, often shortly after birth or in early childhood. Imaging studies, such as X-rays, can reveal specific skeletal abnormalities consistent with the condition, including changes in the vertebrae and long bones. Genetic testing is used to confirm the diagnosis by identifying pathogenic variants in the *COL2A1* gene.

In the UK, referrals for genetic testing for skeletal dysplasias, including Kniest dysplasia, typically follow an NHS Genomic Medicine Service (GMS) pathway. A clinical geneticist or other specialist paediatrician would usually initiate this process. The relevant NHS R-code for testing related to skeletal dysplasias including Kniest is R76.

Management & lifestyle

Management for Kniest dysplasia is supportive and aims to address the specific symptoms an individual experiences. This often involves a multidisciplinary team including orthopaedic surgeons, physiotherapists, audiologists, and ophthalmologists. Regular monitoring of skeletal development, joint health, vision, and hearing is typically recommended.

Physiotherapy and occupational therapy can help maintain joint mobility and improve function. Surgical interventions may be considered for severe joint issues, spinal curvature (kyphoscoliosis), or cleft palate. Hearing aids may be beneficial for hearing impairment, and corrective lenses for vision problems. Genetic counselling can provide information about the condition, its inheritance, and support options available to families.

UK care pathway

In the UK, individuals suspected of having Kniest dysplasia can be referred to clinical genetics services, typically through their GP or a paediatrician. These specialist teams operate within the NHS Genomic Medicine Service (GMS) framework. They can offer a comprehensive assessment, arrange genetic testing (using R-codes such as R76 for skeletal dysplasias), and provide genetic counselling. Genetic counsellors offer crucial support, explaining the condition, inheritance patterns, and helping families navigate the care pathway and access relevant support networks.

Frequently asked questions

Will my child definitely have Kniest dysplasia if I have it?

Kniest dysplasia is inherited in an autosomal dominant pattern. If you have the condition, there is a 50% chance with each pregnancy that your child will inherit the altered gene and also have Kniest dysplasia. Genetic counselling can provide a more detailed explanation of this risk.

What kind of doctors will my child need to see?

Your child will likely need to see a team of specialists. This often includes orthopaedic surgeons for bone and joint issues, physiotherapists, ophthalmologists for eye care, audiologists for hearing, and clinical geneticists for ongoing genetic support and coordination of care.

Is there a cure for Kniest dysplasia?

Currently, there is no cure for Kniest dysplasia. Management focuses on treating the symptoms and complications as they arise to improve quality of life. This can involve therapies, assistive devices, and sometimes surgery.

Can Kniest dysplasia affect learning or intelligence?

Kniest dysplasia primarily affects physical development and typically does not impact intelligence or learning abilities. Children with Kniest dysplasia usually have cognitive development within the typical range, although physical challenges might affect their participation in some activities.

How rare is Kniest dysplasia?

Kniest dysplasia is considered a rare condition. The exact prevalence is not well established, but it is one of the less common skeletal dysplasias. Due to its rarity, diagnosis can sometimes be challenging.

References

  1. Adam MP, Bick S, Mirzaa GM. Type II Collagen Disorders Overview. 1993. PMID: 31021589
  2. Sergouniotis PI, Fincham GS, McNinch AM. Ophthalmic and molecular genetic findings in Kniest dysplasia. Eye (London, England). 2015. PMID: 25592122
  3. Jhamb T, Masood H, Arigo J. Orthodontic Treatment in a Patient With Kniest Dysplasia: A Case Study and Review of Literature. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association. 2019. PMID: 31213073
  4. Kolkıran A, Daşar T, Kablan A. Kniest Dysplasia without Ocular and Auditory Abnormalities in a Boy of 12 Months. Molecular syndromology. 2025. PMID: 40475174
  5. Hochart A, Dieux A, Coucke P. Association between Kniest dysplasia and chondrosarcoma in a child. American journal of medical genetics. Part A. 2015. PMID: 26345137
  6. Spranger J. The type XI collagenopathies. Pediatric radiology. 1998. PMID: 9799295
  7. Sconyers SM, Rimoin DL, Lachman RS. A distinct chondrodysplasia resembling Kniest dysplasia: clinical, roentgenographic, histologic, and ultrastructural findings. The Journal of pediatrics. 1983. PMID: 6358440
  8. Yokoyama T, Nakatani S, Murakami A. A case of Kniest dysplasia with retinal detachment and the mutation analysis. American journal of ophthalmology. 2003. PMID: 14644246
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor.